A B S T R A C T Refsum's disease (heredopathia atactica polyneuritiformis, HAP) is an inherited neurological disorder associated with storage of the branched-chain fatty acid, phytanic acid (3,7,11,15-tetramethylhexadecanoic acid 
A B S T R A C T Refsum's disease (heredopathia atactica polyneuritiformis, HAP) is an inherited neurological disorder associated with storage of the branched-chain fatty acid, phytanic acid (3, 7, 11, 15 -tetramethylhexadecanoic acid). Cultured fibroblasts derived from skin biopsies of HAP patients did not contain elevated levels of phytanate, yet showed rates of phytanate-C-14C oxidation less than 3% of those seen in cells from control subjects. Cells of control subjects converted phytanate to a-hydroxyphytanate, to pristanate (the [n-i] homologue of phytanate) and to 4, 8, 12 -trimethyltridecanoate, compounds previously identified as intermediates on the major pathway for phytanate metabolism in animals, providing the first direct evidence that this same oxidative pathway is operative in human cells. None of these breakdown products could be found after incubation of phytanate with HAP cells. Labeled a-hydroxyphytanate and labeled pristanate were oxidized at normal rates by HAP cells. Oxidation of the latter proceeded at normal rates both when added to the medium at very low tracer levels and at levels 100 times greater. Phytanate was incorporated into and released from lipid esters at normal rates by HAP cells. Elevated levels of free phytanate in the medium were no more toxic to HAP cells than to control cells over the 48-to 72 
INTRODUCTION
Heredopathia atactica polyneuritiformis (HAP) was defined as a clinical entity by Refsum in 1946 (1) . Constant features of the syndrome include retinitis pigmentosa, peripheral polyneuropathy, cerebellar ataxia, and elevated cerebrospinal fluid protein without pleocytosis. Cardiac conduction abnormalities, pupillary changes, nerve deafness, anosmia, ichthyosis, and bony abnormalities occur in a large proportion of cases (2) . An autosomal recessive pattern of inheritance was proposed by Refsum, and additional genetic data support this (3) . In 1963, Klenk and Kahlke showed that the syndrome was associated with accumulation of phytanic acid (3,7,11,15-tetramethylhexadecanoic acid) in blood and tissues (4) . Studies by Steinberg and coworkers (5) (6) (7) (8) have shown that phytanic acid is not synthesized endogenously but originates in the diet and that the patients with HAP have a defect in the oxidative pathway for degradation of phytanic acid. With the recent elucidation of a major pathway for phytanic acid oxidation in animals (9) (10) (11) , it became possible to further localize the defect by testing the ability of patients to oxidize metabolic products of phytanate.
The results presented below show that the enzyme defect in phytanic acid oxidation persists in fibroblast cultures derived from the skin of patients with HAP. Data are presented showing that the alpha-oxidative pathway for phytanate oxidation established by animal studies is present also in human tissues, the first degradation products being a-hydroxyphytanic acid and pristanic acid (2, 6 ,10,14-tetramethylpentadecanoic acid). Finally, it is shown that the rate of oxidation of pristanic acid
The Journal of Clinical Investigation Volume 48 1969 and of a-hydroxyphytanic acid is unimpaired in the paa-hydroxyphytanic acid-U-14C was prepared from phytanic tients' cultured cells, indicating that the principal enzyme acid-U-~C by bromination and hydrolysis in aqueous methadefect lies in the production of a-hydroxyphytanic acid, nol. The product after methylation behaved as a single com-' ponent on GLC and its mass spectrum, determined using the presumably the first step in phytanic acid oxidation. LKB-9000 combined GLC-mass spectrometer, was characPreliminary reports of some of these findings have ap-teristic for the methyl ester of an a-hydroxy acid (17) . On peared (12) (13) (14) .
the other hand, two distinct bands were resolved by TLC (ethyl acetate-hexane, 10: 90 ; Rf values, 0.38 and 0.33).
METHODS
The hydroxyphytanate radioactivity was equally divided between the two bands (upper band, 51%; lower band 49%). Sources and preparation of labeled compounds. Phytol-Actually four stereoisomeric compounds are expected in the U-j4C was purified as previously described (15) from the synthesis of a-hydroxyphytanate from phytol (see Fig. 1 ). nonsaponifiable lipid fraction of algae grown in 'CO2. After Natural phytol (from chlorophyll) has been shown (18, 19) addition of carrier phytol, radiopurity was checked by thin-to have the D configuration at carbon-7 and -11. The absolute layer chromatography (TLC) of phytol itself, TLC after configuration was shown by Kates et al. (20) to be R. No derivative formation (aldehyde and acetyl ester), and by changes at these two asymmetric centers should occur during radioassay of fractions collected from a gas-liquid chro-the synthesis from phytol, and their designation is omitted matography (GLC) column (16) (17% ethylene glycol suc-in the following discussion. Reduction of the 2,3-double cinate [EGS] on Chromosorb W, Applied Science Labora-bond of phytol (followed by oxidation of the alcohol functories Inc., State College, Pa.). tion) should give equal amounts of 3-D-and 3-L-phytanic Phytanic acid-U-"C was prepared from labeled phytol acid. Each of these then gives rise to equal amounts of either as described in detail previously (15) or by the fol-2-D-hydroxy and 2-L-hydroxy acid. Thus the four a-hydroxylowing procedure: phytol-U-j4C was reduced to dihydrophy-phytanate species expected are:
tol-U-14C by hydrogenation with platinum oxide in ethanol.' 3-D), and (2-L, 3-L). Separation by TLC into two bands can
The dihydrophytol-U-1`C was then oxidized to phytanic acid-be best explained on the basis of interactions between the U-14C with chromic acid in glacial acetic acid (2 hr). Purity 2-hydroxyl and the 3-methyl groups affecting polarity. Thus of the phytanic acid (>95%) was confirmed by cochroma-one band might be expected to contain (2-D, 3-L) plus (2-L, tography of its methyl ester with authentic methyl phytanate 3-D), while the other would contain (2-D, 3-D) plus (2-L, on several GLC liquid phases and by gas-liquid radiochro-3-L). Resolution of the latter pair certainly would not be matography (16) . Unless otherwise stated, radiopurity of anticipated. In confirmation of this interpretation, the optical each of the labeled compounds used was similarly confirmed rotations of both bands at 589 m/u were essentially zero.
by gas-liquid radiochromatography.
Neither band exhibited a true Cotton effect from 250 to 217
Pristanic acid-U-j'C was prepared from phytanic acid-m/A, but the lower band showed (a)m' = + 1950 ± 20°and a U-14C by a Barbier-Wieland degradation and purified by sudden sharp rise before extinction at 215 m~u.-The upper thin-layer and gas-liquid chromatography (9) . Homophy-zone was very weakly positive at the same wavelength tanic acid-U-j'C was prepared from labeled phytanic acid (a)22g = + 520 ±300. Additional confirmation of the nature by the Arndt-Eistert procedure-treatment of phytanoyl of the two bands was obtained through the hydroxylation chloride with ethereal diazomethane and rearrangement of of 3D, 7D, 1iD phytanic acid kindly supplied by Dr. M. Kates. the diazoketone with a methanolic suspension of silver oxide. This material was converted to its 2-hydroxy derivative and Radiopurity of both pristanic and homophytanic acids was separated as the methyl ester into two bands on TLC identiover 95%. The labeled a-hydroxyphytanate mixtures in the upper and lower TLC bands were used separately as substrates in the tissue culture system, testing for differences between reference cultures and HAP cultures. In the absence of determination of absolute configuration, they are arbitrarily designated "less polar isomers" and "more polar isomers," respectively.
Palmitic acid-9,10-8H and palmitic acid-1-"C were purchased from the New England Nuclear Corp., Boston, Mass. These and all other radioactive fatty acids, with the exception of a-hydroxyphytanate, were purified by GLC of methyl esters before use, as previously described (15) . After hydrolysis of the methyl esters, labeled free acids were converted to potassium soaps with KOH and added to a swirling aqueous solution containing albumin. The amounts of fatty acid used did not exceed the binding capacity of the albumin present, and all solutions were clear when added to the tissue culture media. The methyl ester of a-hydroxyphytanic acid-U-"C was purified by TLC as described above.
Trimethyl silyl ethers were prepared (21) from the eluted a-hydroxyphytanate isomers and subjected to analytical GLC (17% EGS on Chromosorb W) with collection of fractions for radio-assay (16) . Radiopurity greater than 93% was demonstrated. GLC of the nonsilylated a-hydroxyphytanyl methyl ester was unsatisfactory due to adsorptive losses on the column.
Human serum albumin labeled with "'I was obtained from E. R. Squibb & Sons, New York, and used without further purification.
Patient material and initiation of tissue cultures. Three patients with HAP, all of whom had elevated plasma phytanate concentrations, served as donors of tissue for culture. Two, J. S. and K. S., are Irish siblings, first reported in detail by Ashenhurst, Millar, and Milliken (22) , and subsequently studied at the Clinical Center (8) . M. G. is a 23 year old French female whose case history has been reported by Bonduelle and coworkers (23) . Control cultures were derived from four normal volunteers, one patient each with amyloidosis, Niemann-Pick disease, Hurler's syndrome, homocystinuria, and several with as yet undiagnosed storage diseases involving complex lipids.
Methods used in initiating and maintaining fibroblast tissue cultures have been previously described (24) . Biopsies taken in the Clinical Center at NIH were immediately minced and placed in sterile culture medium. Biopsies taken abroad were placed in a vial containing a few milliliters of sterile medium, packed in ice, and shipped air express to Bethesda (48- and then added to the culture. In all cases, the final preparation was clear, indicating completeness of complex formation with albumin. Measurement of fatty acid oxidation. At the end of the incubation, "CO2 was released from the medium by acidifying to pH 2 with HCl. An aliquot of medium was withdrawn through the rubber serum cap for determination of aqueous tritium (released from palmitic acid-3H). During withdrawal of medium, the bottle was oriented so that the surface covered with cells remained uppermost and thus was not exposed to the acidified medium. The gas phase in the bottle was drawn slowly through 10 ml of 5.1 N NaOH while being displaced by saline, which entered through a second needle. With approximately 80% of the atmosphere collected, the bottle's liquid content was returned to neutrality with NaOH and the remaining gas was collected. The cell sheet was then washed three times with Ca'+-and Mg++-free Dulbecco's saline (26) , dispersed and collected using a small volume of 0.05%o trypsin, 0.005% ethylenediaminetetraacetate (EDTA), and 0.2% methyl cellulose. An aliquot of the cell suspension was removed for enumeration in a Coulter counter. The remainder was washed in Dulbecco's saline and sonically disrupted before determination of total protein (27) and lipid radioactivity.
The NaOH containing Na2"COs was slurried with 3.000 g of highly purified anthracene crystals (Fluorescence Grade, (28) . The rate of oxidation of palmitic acid was also determined in each of the cultures studied. In our earliest experiments, one bottle of cells was incubated with palmitic acid-1-'C, while a duplicate bottle was incubated with the branched-chain acid under study. In later studies, palmitate oxidation was determined simultaneously with that of the "C-labeled branched-chain compounds by including palmitic acid-9,10-3H in the same medium. Duplicate aliquots of medium withdrawn at the end of the incubation period were neutralized and lyophilized; the tritium content of the water distilled off was determined in a dioxane-containing scintillation mixture (29) .
Analysis of cell lipid radioactivity. Lipids were extracted from aqueous suspensions of sonically disrupted cells and from medium using chloroform-methanol 2:1 (25 ml/ml). After addition of one-fifth volume of 0.02 N H2S04, chloroform and aqueous phases were separated. In some cases, free fatty acids (FFA) were extracted from the total lipid sample before saponification (30) ; in others, the total lipid fraction (including FFA) was heated at about 80'C for 1-2 hr in 2% NaOH in 95% ethanol (at least 2 ml/mg lipid). An equal volume of distilled water was added and the nonsaponifiable lipids were extracted by shaking three times with equal volumes of hexane. The residual alkaline aqueous phase was acidified and the saponifiable fraction similarly extracted, occasionally with an additional final diethyl ether extraction.
The FFA fraction and the esterified fatty acid fraction from each culture were converted to methyl esters by heating overnight at 600C in 2%o H2SO4 in anhydrous methanol. Radioactivity in individual fatty acid methyl esters was assayed by gas-liquid radiochromatography (16) . Resolution of branched-chain and straight-chain fatty acids was achieved using a mixed liquid phase (7%o EGS plus 1.5% Gaschrom Q) at 175'-1850C with N2 carrier gas flow of 80 ml/min. Labeled a-hydroxyphytanic acid in cell extracts was first partially purified by TLC of the total fatty acid methyl esters after addition of carrier methyl a-hydroxyphytanate (silica gel containing 0.1% Rhodamine 6G; developing solvent: benzene-hexane, 2: 1; R2 of a-hydroxyphytanate, approximately 0.2). The radioactivity specifically associated with a-hydroxyphytanate was then determined by gas-liquid radiochromatography (17% EGS on Chromosorb W).
RESULTS

Time course of fatty acid oxidation in tissue culture
The time course of 'CO2 evolution from labeled fatty acids in tissue culture was examined in two ways. In one experiment gas in individual culture bottles was repeatedly sampled at 8-or 12-hr intervals over a 72 hr period. While minor losses of "CO2 with this procedure could not be excluded, results of two experiments, shown in Fig. 2 , indicate that production of "CO2 from labeled palmitate and pristanate is linear for at least the 1st 48 hr both in control and HAP cultures.
Using a second approach, bottles were removed at intervals from a group of replicates in which approximately equal numbers of cells of the same strain and at the same stage of growth had been incubated with identical aliquots of labeled fatty acid. Results of one such study, in which the (n + 1) homologue of phytanic acid, homophytanic acid, was added to a control cell strain, are shown in Fig. 3 . A constant rate of production of 'CO2
was observed in this study also. In further studies, 48 hr was chosen as the standard incubation time. Several conditions must be observed in order to maintain constant rates of oxidation. The initial ratio of FFA to albumin in the medium must not be too low; evidently uptake falls off as the FFA: albumin molar ratio falls to very low values during the incubation, as reported by Spector and Steinberg for studies with ascites tumor cells (31) . The cell culture must be in a stationary phase, since the cell count at the end of the 48 hr incubation period is used as the basis for expressing results. At albumin concentrations less than 1%, nonlinear rates of oxidation were observed, possibly because the total amount of fatty acid that could be added (and still keep all of the FFA bound to albumin) was so low that a significant fraction of it was utilized in the course of the 48 hr incubation period, causing the substrate concentration to fall over the course of the incubation.
Fatty acid oxidation in control and HAP cultures Oxidation of a-hydroxyphytanate isomers tion, was oxidized at the same high rate in both control As discussed under Methods, the synthesis of a-hyand HAP cultures. There was no significant difference droxyphytanate-U-14C is expected to yield four isomeric between control cultures and HAP cultures in the rate products based on stereoisomerism at the 2-position (hyof oxidation of a-hydroxyphytanate. In control cultures, droxyl group D or L) and at the 3-position (methyl however, the rate of oxidation of a-hydroxyphytanate group D or L) (see Fig. 1 ). One of the two bands rewas considerably slower than that of either phytanate or solved by TLC is assumed to include (2-D, 3-D) plus pristanate. This slow oxidation may reflect difficulty in (2-L, 3-L), while the other includes (2-D, 3-L) plus penetration into mitochondrial sites of oxidation. Recent (2-L, 3-D) a-hydroxyphytanate. Which mixture is represtudies' show that oxidation of a-hydroxyphytanate by sented in the less polar and which in the more polar isolated rat liver mitochondria is slower than that of TLC band is not known. In Table II is shown a comphytanate but is strongly stimulated by addition of carni-parison of the rates of oxidation of these isomeric mixtine. In Table I , the data for both less polar and more tures. In both control and HAP cultures the less polar polar isomers have ben pooled. The separate results with mixture was oxidized more rapidly than the more polar each isomeric fraction are discussed below.
mixture. The less polar mixture is also oxidized more Finally, as shown in Table I 
Analysis of cell lipid radioactivity
To establish first that analyses of cell lipid radioactivity were measuring only firmly bound or incorporated lipid and to evaluate the contribution from adsorbed albumin-bound fatty acid, 'I-labeled human serum albumin (HSA) was incubated with a culture for 48 hr and the washed cells were examined for retained radioactivity. Table III shows that the cell pellet contained only about 0.01% of the initial medium radioactivity. Thus, a culture containing 2 X 10' cells would have irreversibly adsorbed or incorporated only about 1 m/Amole of albumin in 48 hr or, assuming a constant rate, 6 X 10' molecules/cell per hr. This figures agrees closely with results of published studies on the rate of albumin uptake by human and animal tumor cells in culture (32, 33) . Uptake of FFA attributable to uptake or adsorption of albumin is insignificant, then, relative to the observed over-all rates of fatty acid uptake and shown in Fig. 4 . In addition to the added substrate phytanate-"C, there was significant radioactivity in pristanate and in 4,8,12-trimethyltridecanoate. The latter two fatty acids have been identified previously as degradation products on a major pathway for phytanic acid catabolism in animals (9-11). Quantitative results in four cell cultures of different origin are shown in Table VII . The present findings provide the first evidence that this same pathway is operative also in human cells. The appreciable incorporation of radioactivity into the normal 16-and 18-carbon fatty acids presumably occurred by breakdown of phytanate and reincorporation of labeled fragments. The fatty acids extracted from an HAP culture similarly incubated with labeled phytanate showed, in striking contrast, only the parent phytanate peak (Fig. 5) . Thus, there was no evidence either of breakdown into shorter branched-chain intermediates or of reincorporation of phytanate-"C into straight-chain fatty acids.
Control cultures yielded in addition a small GLC peak of radioactivity with a retention time about twice that of phytanate (Fig. 4) . This radioactive component cochromatographed with authentic carrier a-hydroxyphytanate on both a polar (EGS) and a nonpolar silicone liquid phase (OV-1). It accounted for 0.3-1.3% of total fatty acid radioactivity added to the control cultures (Table VII) . None was detected in HAP cultures. As a further check on the identification of this radioactive component, the mixture of fatty acids (as methyl esters) derived from total lipids of two control cultures incubated with phytanate-14C were fractionated by TLC after addition of carrier methyl a-hydroxyphytanate (benezene-hexane, 2: 1; Ri of hydroxyphytanate, 0.2). The material of the a-hydroxyphytanate zone was eluted from the silicic acid and then fracionated by GLC. 70-80% of the total radioactivity in the TLC band cochromatographed on GLC with the carrier methyl a-hydroxyphytanate.
Studies to rule out a metabolic block subsequent to formation of pristanic acid
The striking contrast between the relative inability of HAP cultures to oxidize phytanate and their almost normal ability to oxidize pristanate and a-hydroxyphytanate indicated a metabolic block before the formation of the latter two metabolites. On the other hand, we still had to consider the possibility that the block lay distal to pristanate. The results could be compatible with this possibility on the following basis. The substrate concentrations of pristanate used when testing for its oxidation were probably considerably higher than those presented to the cell when pristanate was being generated by breakdown of substrate phytanate. Thus, for example, the cells might contain enzymes for pristanate oxidation that had a higher than normal Km value. When presented with a high concentration of pristanate in the medium, such an altered enzyme system might yield an over-all normal net rate of substrate utilization yet be unable to oxidize pristanate normally homologue of phytanic acid. As discussed later, the metabolic error in HAP apparently involves the a-oxidation system, whereas the /-oxidation system appears to be intact, as evidenced by the normal rates of oxidation of pristanic acid. If this interpretation is correct, HAP cells might be expected to oxidize the next higher homologue of phytanic acid, homophytanic acid, at a normal rate. In homophytanic acid (Fig. 6) , the first branch-methyl group is in the gamma position and the beta position is available for oxidative attack as in classical beta oxidation. The product of such beta oxidation would be pristanic acid. Thus, the use of homophytanate-"C as substrate provides a test of whether it is specifically the beta methyl group that makes phytanate difficult for HAP cells to metabolize. If oxidation of homophytanate were normal, it would also indicate that pristanate generated within the cells is in fact oxidized at a normal rate (see discusion above). As shown in Table IX , there was no difference between control and HAP cells in the rate of oxidation of homophytanate-U-14C nor in its total uptake into cell lipids.
Release of phytanate from ester forms
Another explanation considered for the poor rate of phytanate oxidation in HAP cells was that there might AT NORMAL RATE ? FIGURE 6 Oxidation of homophytanic acid, the next higher homologue of phytanic acid. In other words, phytanate might be taken up and esterified normally but could not then be released and made available for oxidation, i.e., it might be "trapped" in ester forms. The following experiment was carried out in an attempt to detect differences in release of phytanate from previously labeled cells. Control and HAP strains were incubated for 48 hr with 'C-labeled phytanate and palmitate-8H in the usual way. The cells were then washed free of labeled medium and fresh medium was added. The cells were next incubated for an additional 24 hr in the unlabeled medium. 'CO2 was collected, 'H20 determined, and lipids were extracted from the medium by the method of Dole (34) and assayed for radioactivity. Cells were collected and cell lipid radioactivity measured. Intracellular radioactivity at the beginning of the second incubation was taken as the sum of cell lipid radioactivity and lipid radioactivity released to the medium. As shown in Table X , control and HAP cells released nearly identical percentages of labeled endogenous material in 24 hr. Other aliquots of medium were extracted similarly and separated into lipid classes by TLC (hexanediethyl ether-HAC, 90:10:2). Approximately 40% of the released radioactivity was .in the free fatty acid zone. Gas-liquid radiochromatography showed that essentially all of this radioactivity was in phytanic acid in both HAP and control cultures. The TLC bands representing cholesterol and complex lipid esters each contained radioactivity, suggesting that membrane debris suspended in the medium contributed to the total lipid or that there was exchange with the lipoprotein lipids of the medium. t 14C and 3H as percentage of calculated total cell lipid radioactivity present at beginning of second incubation. The latter was taken to be the sum of lipid radioactivity released and that extracted from cells at the end of the second incubation.
Toxicity of branched-chain fatty acids
Because fatty acid anions are known to be damaging to cell membranes under some circumstances, the possible contribution of such effects had to be considered. Two specific questions were tested experimentally. First, is phytanic acid more toxic to cultured fibroblasts than straight-chain fatty acids? Second, are fatty acids, in particular phytanic acid, more toxic to HAP cells than to normal cells in culture? One strain of control cells and two HAP strains were grown in medium containing free fatty acids over a wide range of concentrations.
These concentrations were chosen to correspond to FFA: albumin molar ratios ranging from 0.025 to 6.4. The effects of phytanic acid, pristanic acid, and palmitic acid were compared. Duplicate cultures exposed to each concentration of FFA were examined unstained under the light microscope after 24 and 48 hr for the presence of cytoplasmic granulation and vacuolation, loss of cellular attachment to the glass surface, and disorganization of the cell sheet. Below FFA: albumin molar ratios of 3.2 there was no evidence of a toxic effect by these criteria. The abnormalities noted above were present in mild form at a molar ratio of 3.2 and were severe at a molar ratio of 6.4. However, there was no evident difference in toxicity among the three fatty acids tested, nor were there any evident differences in toxicity in control and HAP cells.
DISCUSSION
These tissue culture experimental results support and complement the conclusion drawn from clinical studies reported previously from this laboratory (13, 35) , namely, that there is a primary block in phytanate degradation in HAP. In those reports and in a companion paper (36) , it was shown that HAP patients converted orally administered phytolj'C or intravenously administered phytanic acid-j4C to '4CO2 at much slower rates than did normal controls. Phytanic acid radioactivity also persisted at much higher levels and for longer periods in the patients' plasma than in that of the controls. Although a metabolic block in the oxidation of phytanic acid seemed a likely explanation for these findings, this interpretation was complicated by the presence in the patients of large pools of unlabeled phytanate. While several lines of indirect evidence suggested that the fractional turnover of phytanic acid would not be grossly depressed by even large increases in pool size (8, 15) , some dilutional effects could not be ruled out. In the present studies in cultured cells the problem of isotope dilution does not arise. GLC analyses of the HAP cell lipids after three to five pasages showed negligibly low phytanate levels. Both control and HAP cells showed traces of phytanate (probably attributable to the presence of phytanate in the fetal bovine serum used in the medium, less than 0.2% of total fatty acids). However, there was no difference between HAP and control cells in this regard. Accordingly, the greatly depressed rate of phytanic acid oxidation in HAP cultures, in none of which appreciable phytanate pools could be demonstrated, leaves little doubt that there is a primary defect. Preliminary results in fibroblast cultures from 11 additional documented cases of HAP have shown rates of phytanate oxidation less than 5% of the rates in control cultures.!
The present results lead us to conclude further that the defect lies in the conversion of phytanate to a-hydroxyphytanate. This conclusion draws in part on our previously reported results in animals showing that a major oxidative pathway involves initial alpha-oxidation, to yield the (n-1) fatty acid (pristanic acid), followed by successive beta oxidations to yield lower degradation products as shown in Fig. 7 (9, 10) . That this is in fact a major pathway was shown by the very high yields of pristanic acid-'4C after injection of phytanic acid-1'C. Moreover, after feeding of large doses of phytanic acid, GLC-mass spectrometry failed to reveal accumlation of any intermediates other than those shown in Fig. 7 even though spectra were obtained on all peaks. Nor, after injection of phytanate-"C, was radioactivity found in any branched-chain acids other than those shown in Fig. 7 . Hansen, Shorland, and Prior have confirmed the accumulation of pristanate and 4,8,12-trimethyltridecanoate in phytanic acid-fed rats (37, 38) . More If, and only if, these compounds are intermediates in the oxidation of phytanate, as they appear to be in the mouse and rat, do the results localize the metabolic error at this initial alpha hydroxylation step. Thus the analyses of labeled products of phytanate oxidation in the cell lipids are of central importance.
a-hydroxyphytanate-1'C, pristanate-"C and 4,8,12-trimethyltridecanoate-1'C were all identified in normal fibroblasts after incubation with phytanate-1C. No other labeled compounds could be detected. These findings provide the first direct evidence that the alpha-oxidative pathway for phytanic acid oxidation described in animals occurs also in human cells. In contrast, the cell lipids in HAP cultures contained none of these compounds, only the added substrate phytanate-14C being demonstrable. All of these findings taken together appear to justfy the conclusion that the HAP cells lack some component of an alpha-hydroxylating system (Fig. 8 (43) . Because of the more or less close analogy in structure between phytanate and farnesoic acid, the latter being one isoprenoid unit shorter and being triply unsaturated, the possibility arose that C02 fixation might be involved as it is in the mechanism described by Seubert and Remberger (44) . An apparent C02 requirement for oxidation of a "model" compound (3,6-dimethylactanoate) was noted by Eldjarn, Try, and Stokke (45) , but this was subsequently attributed to changes in oxygen tension (42) . Neither in the present studies nor in previous animal studies has there been evidence of the intermediate expected from an analogous pathway for phytanate degradation (9-11, 37, 38) . After administration of 3,6-dimethyloctanoate-8-14C to man, most of the urinary metabolites were omega oxidation products, as discussed above, but about 1.5% of the total was found in the (n-1) acid (42, 46) . HAP patients, on the other hand, excreted none of the alpha oxidation product and produced little or no "4CO2. These results and recent studies by Stokke (47) provide confirmatory evidence for the presence of an alpha-oxidative pathway. They are also compatible with our conclusion regarding the nature of the metabolic error in HAP if this "model" compound is indeed oxidized by the same enzyme systems that oxidize phytanate. Because so large a fraction of 3,6-dimethyloctanoate is handled by omega oxidation, whereas this appears to be a minor pathway for phytanate oxidation, the validity of it as a model compound should be directly checked.
Try (48) has compared oxidation of 3,6-dimethyloctanoate-8-14C and of randomly labeled 3,14,14-trimethylpentanoic acid in controls and in two HAP patients whose phytanate stores had been reduced by dietary means (49) . The results indicated that the patients oxidized these compounds at one-third to one-half the normal rates. Labeled metabolites were excreted in amounts too low to be fully characterized. In view of the apparently very large capacity of the normal organism to metabolize phytanate (15), it is not certain that this degree of impairment would lead to phytanate accumulation. One cannot exclude the possibility that phytanate may be oxidized relatively more rapidly in vivo than in fibroblast cultures due to contributions of other organ and cell types. However, as reported in the accompanying paper (36) , in vivo oxidation of phytanate itself in the three HAP patients studied here was impaired to an extent comparable to that seen in fibroblast cultures.
The present results demonstrate marked loss of phy-tanic acid-a-hydroxylase activity, but do not differentiate among several possible explanations for it (suppression of enzyme protein synthesis, synthesis of an altered enzyme protein, impairment of a cofactor regenerating system, or other secondary basis for low activity).
Assay of activity in cell-free systems with control of cofactor concentrations and, ultimately, isolation and characterization of the enzyme protein would be desirable. Recent studies in the rat have shown that the enzyme is predominantly intramitochondrial and suggest a role for NADPH and ferric ion (50) . However, attempts to solubilize activity have thus far been unsuccessful. The possibility has been raised that failure to hydrolyze phytanic acid contained in lipid esters may be involved in the pathogenesis of HAP (35) . Although Laurell has shown that synthetic glyceryl triphytanate is resistant to hydrolysis by lipoprotein lipase obtained from healthy subjects after heparin injection (51), the enzymatic capacity of HAP patients, particularly with regard to release from tissue stores, has not been directly investigated. The present experiments with cultured human cells attempted to provide a direct test of the hypothesis. The finding that HAP and control strains released equivalent amounts of labeled phytanate after being washed and reincubated in unlabeled medium makes it seem unlikely that a defect in ester hydrolysis plays a major role in HAP.
The relationship between phytanate accumulation and the symptoms of HAP remains uncertain. Malfunction of lipid membranes into which phytanate is unavoidably incorporated represents the most straightforward hypothesis linking the two (7, 8, 52) . However, repeated attempts to induce neurological abnormalities in experimental animals by feeding phytol or phytanic acid, often at toxic levels and beginning during gestation (53, 54 ,') have been unsuccessful. In the present study, short-term exposure of fibroblasts to moderate levels of unlabeled phytanic acid produced identical morphological changes in HAP and normal strains. These changes began at the same threshold level as did similar effects with palmitate. Subsequent studies extending over longer periods' have provided suggestive evidence for a selective growth inhibitory effect of phytanic acid on HAP cultures. Consistent with this observation are reports of marked growth retardation in two cases of HAP presenting an unusually early onset soon after birth (55, 56) . The possibility remains that displacement of normal structural fatty acids by excess phytanate may be responsible for the manifestations of HAP.
Another hypothesis would suppose that the alpha hydroxylating enzyme absent in HAP, in addition to ' disposing of phytanate, normally plays a second and more crucial metabolic role in nervous tissue. Considerable evidence exists for the occurrence of alpha oxidation and the participation of long-chain alpha hydroxy fatty acids in brain and nerve metabolism (57) (58) (59) .
However, attempts to demonstrate oxidation of phytanate in nervous tissue or alpha hydroxylation of lignocerate in cultured fibroblasts6 have so far been negative. Further, the phytanate oxidizing system has now been shown to have properties quite different from those of the brain alpha oxidizing system (60). Finally, two independent studies on postmortem tissue have failed to demonstrate abnormal patterns or concentrations of long-chain, straight-chain alpha hydroxy acids in HAP nervous tissue (61, 62) .
A third possibility is that phytanic acid interferes with the function of fat-soluble vitamins such as A, E, or K, or with other essential cofactors with closely related side chains. However, large doses of these materials or of unsaturated fatty acids failed to protect experimental animals against toxic effects of oral phytol (53, 7) Finally, it remains possible that deletion of phytanate hydroxylation is separate from the defect responsible for the clinical manifestations of HAP but closely linked to it on the same chromosome. The proposal that on this or some other basis phytanate storage is not directly the cause of the clinical changes may also explain the discovery of patients who are clinically indistinguishable from those with HAP but who have normal phytanate levels, oxidize phytanate normally in vivo, and whose cultured fibroblasts oxidize phytanic acid at normal rates (63, 8) . If further clinical observations confirm the previously noted improvement on phytanic acid-low diets (49) , however, a simple cause and effect relationship can be accepted.
